Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

TSE:RHEL Stock Latest News

The FlyPsychedelic: Clearmind completes recruitment for AUD cohort of CMND-100 trial4d agoBMY CMND

Company AnnouncementsRhelion’s Filament Health to Supply Psilocybin Candidate PEX010 for Swedish Social Anxiety Trial5d ago
The FlyPsychedelic: Optimi completes MDMA production for three programs1w agoPBM ENVB
Company AnnouncementsRhelion’s Filament to Supply Psilocybin for Belgium’s First Compassionate Use Program2w ago
The FlyPsychedelic: NRx Pharmaceuticals receives FDA labeling review letter2w agoDFTX DRUG

Rhelion Reappoints Psychedelic Research Leader as Advisor and Moves to Restructure Debt

Company AnnouncementsRhelion Reappoints Psychedelic Research Leader as Advisor and Moves to Restructure Debt2w ago

Company AnnouncementsRhelion Subsidiary Filament to Supply Psilocybin for UCSF Trial on Meth Use Disorder in People With HIV3w ago

The FlyPsychedelic: Psyence BioMed announces exclusive U.S. ibogaine license1M agoPBM CMND

Company AnnouncementsRhelion Unit Ships Psilocybin Candidate for PTSD Trial in Calgary1M ago
Company AnnouncementsRhelion’s Filament Unit Boosts Psilocybin Supply for Landmark Italian Depression Trial1M ago
The FlyPsychedelic: Optimi completes psilocybin production for Phase 2 trial1M agoPBM CMND
Company AnnouncementsRhelion Subsidiary Filament Health Wins New Canadian Patent for Natural Psilocybin1M ago

Rhelion Subsidiary Supplies Psilocybin for Phase 3 Palliative Care Trial

Company AnnouncementsRhelion Subsidiary Supplies Psilocybin for Phase 3 Palliative Care Trial1M ago

The FlyPsychedelic: Definium’s LSD-based drug meets endpoints in GAD study1M agoLLY PBM

Company AnnouncementsRhelion’s Filament Health inks psilocybin supply deal with Dutch research centre1M ago

Company AnnouncementsRhelion’s Filament Health to Supply Psilocybin Candidate PEX010 for USC Mindfulness Trial1M ago
The FlyPsychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy1M agoCMND CMPS
Company AnnouncementsRhelion Unit Filament Ships Psilocybin Drug to Australia for First-of-Its-Kind FND Trial1M ago
Company AnnouncementsRhelion Subsidiary Ships Psilocybin Candidate to Australia for Novel Movement Disorder Trial1M ago

Psychedelic: Clearmind initiates Phase IIa of CMND-100 trial

The FlyPsychedelic: Clearmind initiates Phase IIa of CMND-100 trial2M agoCMND MIRA

Company AnnouncementsRhelion Expands Role in EU Psilocybin Access With New PEX010 Delivery to Germany2M ago

Company AnnouncementsRhelion Life Sciences Marks Transformational Quarter With Filament Acquisition and Psychedelic Drug Push2M ago